IMNM
Immunome, Inc.stockNASDAQ
Market OpenNov 19, 2026 3:07:39 PM EST
16.57USD-1.251%(-0.21)424,641
Pre-marketNov 19, 2026 8:58:30 AM EST
16.80USD+0.119%(+0.02)
IMNM Financials
In Q3 FY 2026 (ended ), Immunome, Inc. (IMNM) reported revenue of $0, net income of −$85.78M, operating cash flow of −$60.75M, and assets of $505.53M (filed ).
Loading financial statements…